Results 51 to 60 of about 29,367 (217)

Ionic–Bionic Interfaces: Advancing Iontronic Strategies for Bioelectronic Sensing and Therapy

Advanced Science, EarlyView.
Ionic–bionic interfaces for bioelectronics leverage ions as multifunctional mediators that combine mechanical compliance, ionic and electronic functionalities, and therapeutic effects. These systems offer real‐time biosignal transduction, effective wound dressing, responsive drug delivery, and seamless interaction between soft tissues and electronic ...
Yun Goo Ro, Yoojin Chang, Jeeyoon Kim, Seungjae Lee, Sangyun Na, Cheolhong Park, Hyunhyub Ko   +6 more
wiley   +1 more source

One Year of Alendronate Treatment Lowers Microstructural Stresses Associated with Trabecular Microdamage Initiation [PDF]

, 2010
Alendronate, an anti-remodeling agent, is commonly used to treat patients suffering from osteoporosis by increasing bone mineral density. Though fracture risk is lowered, an increase in microdamage accumulation has been documented in patients receiving ...
Allen, Matthew R., Burr, David B., Diab, Tamim, Guldberg, Robert E, O'Neal, Jessica M, Vidakovic, Brani   +5 more
core   +2 more sources

Effect of Vitamin K and Alendronate Combination Treatment on Bone Mineral Density of Postmenopausal Osteoporosis Patients: A Pilot Study [PDF]

Patient Safety and Quality Improvement Journal, 2016
Introduction: Osteoporosis is a common problem in postmenopausal women. Numerous studies investigated the effects of vitamin K on bone health, which yielded conflicting results.
Mohammad Hassan Jokar, Zahra Mirfeizi, Habiballah Esmaili, Mohsen Khamoshi   +3 more
doaj  

Alendronate Sodium as Enteric Coated Solid Lipid Nanoparticles; Preparation, Optimization, and In Vivo Evaluation to Enhance Its Oral Bioavailability. [PDF]

PLoS ONE, 2016
Treatment of osteoporosis with alendronate sodium has several challenges. The first challenge is the low bioavailability. The second main challenge is side effects, which include oesophageal ulceration.
Khaled Mohamed Hosny
doaj   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

Arthritis &Rheumatology, Accepted Article.
Background Transition from long‐term denosumab to PTH‐analogs or romosozumab might expose patients to the risk of the so‐called rebound phenomenon. Adding romosozumab to denosumab might represent an option in patients experiencing a fracture while on denosumab.
Giovanni Adami, Francesco Pollastri, Angelo Fassio, Filippo Montanari, Anna Piccinelli, Camilla Benini, Emma Pasetto, Carmen Dartizio, Davide Gatti, Maurizio Rossini, Ombretta Viapiana   +10 more
wiley   +1 more source

The nurse of the Mediterranean [PDF]

, 2010
During the First World War Malta did not take an active part in the fighting. Britain was joined in an ‘entente’ a friendship agreement with France since 1904 and later with Russia in 1907.
Pisani, Saviour
core  

Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature. [PDF]

, 2017
There has been a conscious effort to address osteoporosis in the aging population. As bisphosphonate and intermittent parathyroid hormone (PTH) therapy become more widely prescribed to treat osteoporosis, it is important to understand their effects on ...
Acosta, Frank L, Hah, Raymond, Hsieh, Patrick C, Iorio, Justin A, Jakoi, Andre M, Liu, John C, Patel, Neil N, Pham, Martin H, Stone, Michael A, Wang, Jeffrey C   +9 more
core   +2 more sources

Development of Tunable Materials From Well‐Defined Alendronic Acid Functionalized Polyacrylamide: An Opportunity for Actinide Decontamination

Journal of Polymer Science, EarlyView.
Alendronate‐based copolymers for Nd and Ce recovery. ABSTRACT Bisphosphonic acid groups are emerging as promising functionalities for actinide decontamination, due to their high density of chelating sites. However, the chemistry of bisphosphonate (in particular alendronate) materials remains complex and underexplored.
Vincent Darcos, Loona Ferrie, Carlos Arrambide, Gabriele Vecchio, Nicolas Dacheux, Stephane Pellet‐Rostaing, Benedicte Prelot, Sophie Monge   +7 more
wiley   +1 more source

Adverse events, bone mineral density and discontinuation associated with generic alendronate among postmenopausal women previously tolerant of brand alendronate: a retrospective cohort study

BMC Musculoskeletal Disorders, 2010
Background A rise in gastrointestinal (GI) adverse events (AEs) and a decline in bone mineral density (BMD) was observed in patients previously tolerant to brand alendronate shortly after generic versions were introduced in July 2005 to the Canadian ...
Papaioannou Alexandra, Grima Daniel T, Airia Parisa, Ioannidis George, Adachi Jonathan D   +4 more
doaj   +1 more source

Clinical practice guidelines for the diagnosis and treatment of osteoporosis secondary to ankylosing spondylitis

Rheumatology &Autoimmunity, EarlyView.
Ankylosing spondylitis (AS) is a chronic inflammatory disease that primarily affects the axial skeleton and is often associated with secondary osteoporosis. Currently, there are no established international consensus or guidelines for managing AS‐related osteoporosis (AS‐OP). This guideline was jointly developed by several Chinese academic institutions,
Yasong Li, Liang Wang, Hongzhi Wang, Han Wang, Huaxiang Wu, Qifeng Ying, Dongbao Zhao, Lan He, Xuewu Zhang, Jian Zhu, Sanzhong Xu, Yi Yuan, Dun Hong, Peijian Tong, Ping Huang, Zhenchun Zhang, Hongwei Du, Yizhong Li, Xiaochun Zhu, Lijuan Wang, Zhangxuan Shou, Hao Zhang, Feng Huang, Weidong Xu   +23 more
wiley   +1 more source